Tivus Ultrasound System for Pulmonary Arterial Hypertension Gets FDA Breakthrough Designation
SoniVie, a company based in Israel, won FDA Breakthrough Device Designation for its TIVUS intravascular ultrasound system for patients suffering from pulmonary arterial hypertension (PAH). Currently there are only medications available for PAH and ev...
Source: Medgadget - Category: Medical Devices Authors: Medgadget Editors Tags: Cardiac Surgery Cardiology Vascular Surgery Source Type: blogs
More News: Cardiology | Heart | Hypertension | Israel Health | Medical Devices | Middle East Health | Pulmonary Artery Catheterization | Pulmonary Hypertension | Sports Medicine | Study | Ultrasound